Advertisement

Topics

FDA Approves Once-Daily QTERN® (Dapagliflozin and Saxagliptin) Tablets for Adults with Type-2 Diabetes

02:10 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
QTERN fixed-dose combination will provide an additional oral medicine option for patients taking FARXIGA® (dapagliflozin) to improve blood sugar level AstraZeneca (NYSE:AZN) today announced that the US Food and Drug ...

Other Sources for this Article

AstraZeneca
Michele Meixell, + 1 302 885 2677
or
Abigail Bozarth, + 1 302 885 2677

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Once-Daily QTERN® (Dapagliflozin and Saxagliptin) Tablets for Adults with Type-2 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...